Product Name: 5-Amino-2,4,6-triiodoisophthalic acid
Synonym: 2,4,6-Triiodo-5-aminoisophthalic acid; ATIPA; Intermediate of Iohexol; Intermediate of Ioversol; Intermediate of Iopamidol
Cas No.: 35453-19-1
Formula: C8H4NO4I3
MW: 558.84
EINECS No.: 252-575-4
HS Code: 2942000000
UN No.: Not dangerous goods
Specification
Items of Analysis | Standard of Analysis | Test Results |
Appearance | Light yellow or off-white powder | Conform |
Purity (HPLC) | ≥98.5% | 99.69% |
Melting Point | 265-270℃ | 266.6-268.3℃ |
Loss on drying | ≤1.0% | 0.47% |
Any other individual impurity | ≤0.5% | Conform |
Total sum of impurities | ≤1.5% | 0.31% |
Conclusion | Conforms to Factory Standard |
Application
An important intermediate for nonionic iodinated X-ray contrast agents such as Iohexol, Ioversol and Iopamidol.
Packaging
25 kg/barrel, can also be packaged according to customer requirements.
Storage
Store in a cool, ventilated warehouse.
Keep away from fire and heat.
The temperature should not exceed 37 °C.
We are professional 5-Amino-2,4,6-triiodoisophthalic acid manufacturer and Intermediate of Iopamidol supplier in China, We offer quality ATIPA you can fully trust, also we have India factory and producer of Intermediate of Ioversol,Pls send inquiry of Intermediate of Iohexol CAS:35453-19-1 to info@nbinno.com if you have any interests, thank you!
Related News: The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.Diisopropyl azodicarboxylate CAS:2446-83-5 The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium Hexafluorophosphate In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.DL-Histidine Monohydrochloride Monohydrate Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.
![](https://www.nbinno.com/upload/ad/1594704186835765.png)